ARQT
Arcutis Biotherapeutics, Inc.
NASDAQ · Healthcare · Biotechnology · US
$23.90
+1.01%Leverage
- Debt / equity
- 0.52x
- Net debt / equity
- 0.36x
- Debt / assets
- 0.23x
- Debt / EBITDA
- 2.59x
- Net debt / EBITDA
- 1.81x
Liquidity & coverage
- Current ratio
- 2.92x
- Quick ratio
- 2.67x
- Cash ratio
- 1.49x
- Interest coverage
- 2.47x
- EBITDA / interest
- 3.19x
- Working capital
- $307.3M
Cash & dividend
- FCF / debt
- 0.34x
- Cash flow / debt
- 0.34x
- Dividend per share
- —
- Dividend yield
- —
- Dividend growth 1y
- —
Leverage, liquidity, debt coverage and shareholder-distribution metrics · Data as of Jun 1, 2026